AMD stock today: Advanced Micro Devices slips as year-end tech trade cools

AMD stock today: Advanced Micro Devices slips as year-end tech trade cools

NEW YORK, December 30, 2025, 10:16 ET — Regular session

Advanced Micro Devices shares edged down about 0.3% to $214.97 in early trade on Tuesday, after opening at $216.00 and moving between $214.76 and $216.54.

The stock’s drift lower came as Wall Street opened subdued, with the S&P 500 and Nasdaq little changed after a tech-led pullback the prior session.

Why it matters now: the market is in the final stretch of 2025, when liquidity can thin and small swings in mega-cap tech tend to spill into chip stocks. “This is (not) the beginning of the end of the tech dominance, it’ll turn out to be a buying opportunity,” said Hank Smith, director and head of investment strategy at Haverford Trust, as investors awaited minutes from the Federal Reserve’s last meeting, a detailed account of policymakers’ discussion. Reuters

Semiconductors also stayed in focus after three people familiar with the matter said China is requiring chipmakers to use at least 50% domestically made equipment when adding new capacity, part of a broader push to localize its supply chain.

Separately, two people familiar with the matter said the U.S. government granted Samsung Electronics and SK Hynix annual licenses to bring chipmaking equipment to their China facilities for 2026, as Washington shifts to a tighter export-licensing system.

In U.S. trading, Nvidia was down about 0.4% while Intel rose about 2%, and a major semiconductor ETF was little changed — a mixed tape that left AMD without a clear sector tailwind. A filing disclosed Monday showed Nvidia completed a $5 billion purchase of Intel shares under a previously announced agreement.

Company-specific news was sparse. A list of recent SEC filings on AMD’s investor relations website shows its latest posting was dated Dec. 23, with no fresh disclosures in the past week to redirect trading.

Investors have been leaning more on forward-looking product expectations heading into 2026. MarketWatch reported that analysts including TD Cowen’s Joshua Buchalter see AMD’s planned Instinct MI450 accelerators and its Helios rack-scale systems as central to whether AMD narrows the gap with Nvidia in AI computing.

An “accelerator” is a specialized chip used to speed up AI workloads, while “rack-scale” refers to integrating chips, networking and memory across an entire server rack rather than optimizing a single board — an approach hyperscalers use to squeeze more performance out of data centers.

The next near-term catalyst is AMD’s CES 2026 keynote. The company said CEO Lisa Su will deliver the CES opening keynote on Jan. 5 at 9:30 p.m. ET, where investors will listen for updates on its PC and AI roadmap and any partner announcements.

For traders, the immediate watch is whether AMD holds around the $215 level after a Monday tech selloff and ahead of Fed minutes, with year-end positioning likely to keep moves choppy into the New Year holiday.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech. Her coverage ranges from stocks and technology to emerging industries and developments across global markets. She studied economics and finance at the London School of Economics and worked in market research before becoming a financial journalist. Follow Khadija Saeed on Google News.

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 Strong buy

Alphabet

NASDAQ:GOOGL 92/100 • ★★★★½
#2 Strong buy

Taiwan Semiconductor Manufacturing

NYSE:TSM 89/100 • ★★★★½
#3 Buy

S&P Global

NYSE:SPGI 88/100 • ★★★★
#4 Buy on weakness

Amazon

NASDAQ:AMZN 86/100 • ★★★★
#5 Buy on weakness

Microsoft

NASDAQ:MSFT 84/100 • ★★★★
View full portfolio
Editorial model selection. Not personalised advice.
Why Caterpillar stock is riding an AI data-center generator boom
Previous Story

Why Caterpillar stock is riding an AI data-center generator boom

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade
Next Story

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade